Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Named profile Baituxiao Botanical Formula: Product, Label and Evidence ProfileRepresentative category illustration – no product packaging is shown.Baituxiao Botanical Formula: Product, Label and Evidence Profile
Baituxiao is marketed as a botanical supplement for pet wellness, comfort, vitality and normal immune function. It is not an FDA-approved cancer drug, and the manufacturer's own disclaimer…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Circulating Tumor DNA and Multi-Cancer Blood Tests: Evidence Boundary
Emerging blood-based cancer assays may be discussed for selected questions, but validation, false results, follow-up pathways, and device oversight require careful review.
Read more
Sentinel Lymph Node Mapping Before Node Biopsy or Removal
Sentinel-node mapping aims to identify the first draining node, which may not be the nearest or largest node, before sampling or surgery.
Read moreImage-Guided Tumor Ablation and Embolization: Emerging Veterinary Options
Image-guided local procedures may be discussed at specialist centers for selected tumors, but indications, access, evidence, and follow-up remain technique- and diagnosis-specific.
Read more
Gemcitabine in Veterinary Oncology: Limited and Protocol-Specific Evidence
Gemcitabine is an intravenous antimetabolite considered in selected veterinary protocols, where evidence and toxicity must be reviewed for the exact diagnosis.
Read moreTaxane Chemotherapy: Formulation, Infusion, and Evidence Questions
Taxanes disrupt microtubule dynamics, but formulation, infusion reactions, species experience, and veterinary evidence differ enough that product names are not interchangeable.
Read moreElectrochemotherapy: Local Treatment With an Emerging Evidence Base
Electrochemotherapy combines electric pulses with a selected antineoplastic agent to increase local drug uptake and is available only in some veterinary settings.
Read more
Imatinib in Canine Mast Cell Tumor Care: Extra-Label Evidence Review
Imatinib has published canine mast cell tumor experience but is not interchangeable with veterinary-labeled TKIs and requires specialist, legal, formulation, and evidence review.
Read more
Prehabilitation Before Major Cancer Surgery
Prehabilitation prepares selected patients and households for surgery through safe conditioning, pain control, nutrition, equipment, and recovery planning without delaying urgent treatment.
Read moreLimb Swelling and Lymphedema: Measurement and Gentle Management
New swelling after tumor, node surgery, radiation, thrombosis, infection, or immobility needs diagnosis before compression, massage, or exercise is attempted.
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read more